Fresenius Medical Care (NYSE:FMS) Shares Gap Down – Should You Sell?

by · The Cerbat Gem

Fresenius Medical Care AG (NYSE:FMS – Get Free Report)’s share price gapped down before the market opened on Friday . The stock had previously closed at $22.48, but opened at $21.85. Fresenius Medical Care shares last traded at $21.91, with a volume of 23,815 shares.

Analysts Set New Price Targets

Several research firms have commented on FMS. Berenberg Bank assumed coverage on shares of Fresenius Medical Care in a report on Wednesday, November 6th. They issued a “buy” rating and a $25.60 price target on the stock. StockNews.com started coverage on Fresenius Medical Care in a research note on Thursday. They issued a “strong-buy” rating on the stock. Finally, Truist Financial lifted their price target on Fresenius Medical Care from $22.00 to $23.00 and gave the company a “hold” rating in a research report on Monday, October 7th.

Read Our Latest Stock Report on Fresenius Medical Care

Fresenius Medical Care Stock Performance

The company has a market capitalization of $12.89 billion, a price-to-earnings ratio of 18.58, a price-to-earnings-growth ratio of 1.03 and a beta of 0.91. The firm has a fifty day simple moving average of $20.93 and a 200 day simple moving average of $20.32. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02.

Institutional Investors Weigh In On Fresenius Medical Care

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Allworth Financial LP grew its position in shares of Fresenius Medical Care by 53.1% in the third quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock valued at $36,000 after purchasing an additional 581 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in Fresenius Medical Care in the 3rd quarter worth about $38,000. GAMMA Investing LLC increased its stake in Fresenius Medical Care by 50.4% during the 3rd quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock worth $106,000 after buying an additional 1,675 shares in the last quarter. ORG Wealth Partners LLC acquired a new position in shares of Fresenius Medical Care during the third quarter valued at approximately $112,000. Finally, Venturi Wealth Management LLC lifted its position in shares of Fresenius Medical Care by 1,045.8% in the third quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock valued at $112,000 after acquiring an additional 4,800 shares in the last quarter. Hedge funds and other institutional investors own 8.25% of the company’s stock.

About Fresenius Medical Care

(Get Free Report)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Further Reading